Contineum Therapeutics
CTNM
#7811
Rank
NZ$0.57 B
Marketcap
NZ$19.56
Share price
2.31%
Change (1 day)
-21.22%
Change (1 year)

Revenue for Contineum Therapeutics (CTNM)

Revenue in 2025 (TTM): N/A

In 2024 the company made a revenue of N/A a decrease over the revenue in the year 2023 that were of NZ$79.06 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Contineum Therapeutics from 2023 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) N/A
2024 N/A-100%
2023 NZ$79.06 M